financetom
Business
financetom
/
Business
/
Coinbase fourth-quarter profit beats on crypto rally
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Coinbase fourth-quarter profit beats on crypto rally
Feb 13, 2025 1:51 PM

(Reuters) -Crypto exchange Coinbase beat estimates for fourth-quarter profit on Thursday, driven by higher trading volumes in bitcoin and other digital tokens following the U.S. election.

Unprecedented interest in crypto, fueled by Donald Trump's victory in the November presidential election, pushed bitcoin beyond $100,000 in the quarter as investors anticipated more crypto friendly policies under the new administration.

Trump has promised to the make the U.S. the "crypto capital of the planet". Paul Atkins, his pick to lead the Securities and Exchange Commission, is known for his pro-crypto views - a sharp contrast to former Chair Gary Gensler, who likened the industry to the "Wild West".

Shares of the company rose more than 3% in extended trading.

Coinbase earned $4.68 per share for the three months ended December 31, while analysts were expecting a profit of $1.81 per share, according to data compiled by LSEG.

The profit included $476 million in pre-tax gains on crypto asset investment portfolio.

Its transaction revenue rose 172% to $1.6 billion. Revenue from subscription and services unit, which houses businesses outside of trading, rose 15% to $641 million.

Total revenue rose to $2.3 billion from $953.8 million a year earlier.

On Wednesday, Robinhood reported a 700% jump in fourth-quarter 0revenue as it benefited from a surge in crypto trading activity.

(Reporting by Jaiveer Singh Shekhawat and Niket Nishant in Bengaluru; Editing by Anil D'Silva)

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
BTU Dixie East Project Approved
BTU Dixie East Project Approved
Oct 27, 2025
VANCOUVER, BC / ACCESS Newswire ( ACCS ) / October 27, 2025 / BTU METALS CORP. ( BTUMF ) (BTU or the Company) (OTCQB:BTUMF) is pleased to announce the acquisition of the 100% interest in the newly secured Dixie East Project, a large and strategically located land package immediately east of Kinross Gold's ( KGCRF ) world-renowned Great Bear Dixie...
Intellia Therapeutics Pauses Dosing in Phase 3 Trials After Grade 4 Liver Transaminases Reported in Participant
Intellia Therapeutics Pauses Dosing in Phase 3 Trials After Grade 4 Liver Transaminases Reported in Participant
Oct 27, 2025
08:01 AM EDT, 10/27/2025 (MT Newswires) -- Intellia Therapeutics ( NTLA ) said Monday it has paused patient dosing and screening for its two phase 3 clinical trials of nex-z for patients with transthyretin amyloidosis with cardiomyopathy and polyneuropathy, respectively, after a patient was reported with Grade 4 liver transaminases and increased total bilirubin after dosage with the drug. The...
Johnson & Johnson Says 2-Year Data for Tremfya in Crohn's Disease Shows Durable Remission
Johnson & Johnson Says 2-Year Data for Tremfya in Crohn's Disease Shows Durable Remission
Oct 27, 2025
08:01 AM EDT, 10/27/2025 (MT Newswires) -- Johnson & Johnson ( JNJ ) said Monday that long-term extensions of its phase 3 studies showed that its drug, Tremfya, maintained high rates of clinical and endoscopic remission in adults with moderately to severely active Crohn's disease through two years. The drugmaker said the studies evaluated patients who received either subcutaneous or...
Organon CEO Kevin Ali to resign after probe into contraceptive sales
Organon CEO Kevin Ali to resign after probe into contraceptive sales
Oct 27, 2025
Oct 27 (Reuters) - Organon said on Monday CEO Kevin Ali will resign from his role, after an internal investigation into sales of its Nexplanon contraceptive implant to wholesalers pointed to improper practices. An audit committee found certain U.S. wholesalers were asked to purchase more Nexplanon than needed at the end of several quarters between 2022 and 2025. While the...
Copyright 2023-2025 - www.financetom.com All Rights Reserved